Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial-Reference-Cited by-同舟云学术

Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial

Published:2023-05 Issue: Volume:28 Page:100613
ISSN:2666-7762
Container-title:The Lancet Regional Health - Europe
language:en
Short-container-title:The Lancet Regional Health - Europe

Author:

Corominas Júlia^ORCID,Garriga Carme,Prenafeta Antoni,Moros Alexandra^ORCID,Cañete Manuel,Barreiro Antonio,González-González Luis^ORCID,Madrenas Laia,Güell Irina,Clotet Bonaventura,Izquierdo-Useros Nuria,Raïch-Regué Dàlia,Gallemí Marçal^ORCID,Blanco Julià,Pradenas Edwards^ORCID,Trinité Benjamin^ORCID,Prado Julia G.,Blanch-Lombarte Oscar,Pérez-Caballero Raúl^ORCID,Plana Montserrat,Esteban Ignasi,Pastor-Quiñones Carmen,Núñez-Costa Xavier,Taleb Rachel Abu^ORCID,McSkimming Paula,Soriano Alex,Nava Jocelyn,Anagua Jesse Omar,Ramos Rafel,Lluch Ruth Martí,Comes Aida Corpes,Romero Susana Otero,Gomez Xavier Martinez,Sans-Pola Carla^ORCID,Moltó José,Benet Susana,Bailón Lucía,Arribas Jose R.^ORCID,Borobia Alberto M.,Parada Javier Queiruga,Navarro-Pérez Jorge,Forner Giner Maria José,Lucas Rafael Ortí,Jiménez María del Mar Vázquez,Compán Salvador Oña,Alvarez-Mon Melchor,Troncoso Daniel,Arana-Arri Eunate,Meijide Susana,Imaz-Ayo Natale,García Patricia Muñoz,de la Villa Martínez Sofía^ORCID,Fernández Sara Rodríguez,Prat Teresa,Torroella Èlia,Ferrer Laura

Publisher

Elsevier BV

Subject

Health Policy,Oncology,Internal Medicine

Reference37 articles.

1. Body localization of ACE-2: on the trail of the keyhole of SARS-CoV-2;Salamanna;Front Med,2020

2. SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies;Yang;Signal Transduct Target Ther,2021

3. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection;Khoury;Nat Med,2021

4. Divergent SARS-CoV-2 Omicron-reactive T and B cell responses in COVID-19 vaccine recipients;GeurtsvanKessel;Sci Immunol,2022

5. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial;Ramasamy;Lancet,2021

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scalable bioprocess for the high-yield production of SARS-CoV-2 trimeric spike protein-based immunogen (IMT-CVAX) using suspension CHO cells;Process Biochemistry;2024-08

2. Exploring future perspectives and pipeline progression in vaccine research and development;ANN IG MED PREV COMU;2024

3. Heterologous versus homologous COVID-19 booster vaccinations for adults: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials;BMC Medicine;2024-06-24

4. A Review of Protein-Based COVID-19 Vaccines: From Monovalent to Multivalent Formulations;Vaccines;2024-05-25

5. Immunogenicity and Safety of SARS-CoV-2 Protein Subunit Recombinant Vaccine (IndoVac®) as a Booster Dose against COVID-19 in Indonesian Adults;Vaccines;2024-05-14